---
title: "Dr Reddys Laboratories Ltd (DRREDDY) — Share Price, Financials & Analysis"
symbol: "DRREDDY"
company: "Dr Reddys Laboratories Ltd"
canonical: "https://tapetide.com/stocks/DRREDDY"
isin: "INE089A01031"
nse_symbol: "DRREDDY"
bse_code: "500124"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 95419.37
generated_at: "2026-09-13T18:25:37.776Z"
---

# Dr Reddys Laboratories Ltd (DRREDDY)

Canonical page: https://tapetide.com/stocks/DRREDDY

## Company

- **NSE Symbol:** DRREDDY
- **BSE Code:** 500124
- **ISIN:** INE089A01031
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2003-05-30
- **CEO:** Mr. Gunupati Venkateswara Prasad B.E.
- **Employees:** 27811
- **Face Value:** ₹1
- **F&O Eligible:** Yes
- **Website:** drreddys.com

## About

Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

## Latest Price

- **Price:** ₹1165.5
- **Change:** +22.5 (+1.97%)
- **Open:** ₹1130
- **Day High:** ₹1182
- **Day Low:** ₹1130
- **Previous Close:** ₹1143
- **Volume:** 2403285
- **As Of:** 2026-09-11T10:28:44+00:00

## Key Fundamentals

Observed at 2026-09-11T04:43:26.612639Z.

- **Market Cap:** ₹95419.37 Cr
- **Classification:** Midcap
- **P/E (reported):** 29.9
- **P/E (TTM):** 30.19
- **EPS (TTM):** ₹38.61
- **EPS (reported):** ₹333.59
- **Book Value:** ₹456.14
- **Price to Book:** 2.5
- **Dividend Yield:** 0.7%
- **ROE:** 10.87%
- **ROCE:** 13.94%
- **Debt to Equity:** 0.2
- **Revenue (yearly):** ₹35058.6 Cr
- **Net Income:** ₹4157.6 Cr
- **EBITDA:** ₹7811.9 Cr
- **52-Week High:** ₹1414.9
- **52-Week Low:** ₹1101
- **RSI (14):** 37.74

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Falling
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 44.07 | 9% |
| growth | 5.32 | 9% |
| momentum | 11 | 12% |
| ownership | 55.29 | 24% |
| quality | 50.35 | 22% |
| valuation | 80.4 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company's working capital requirements have reduced from 85.1 days to 67.8 days

### Weaknesses

- Dividend payout has been low at 13.2% of profits over last 3 years

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 22.2% | 24.88% | 101.85% |
| ebitda margin growth | 42.51% | -22.04% | -27.05% | 15.44% |
| net income growth | 96.84% | -27.38% | -4% | 15% |
| revenue growth | 5.38% | 3.9% | 11% | 12% |
| roce | 122.27% | -36.29% | -44.64% | 20.58% |
| roe | 96.84% | -35.57% | 15.83% | -4.31% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6903 | 7237 | 7114 | 7696 | 8038 | 8381 | 8528 | 8572 | 8828 | 8753 | 7546 | 8100 |
| Expenses | 4894 | 5214 | 5283 | 5566 | 5962 | 6108 | 6530 | 6398 | 6818 | 6866 | 7164 | 7240 |
| Operating Profit | 2008 | 2023 | 1831 | 2130 | 2076 | 2273 | 1998 | 2174 | 2010 | 1888 | 382 | 860 |
| OPM % | 29 | 28 | 26 | 28 | 26 | 27 | 23 | 25 | 23 | 22 | 5 | 11 |
| Other Income | 319 | 219 | 201 | 193 | 314 | 154 | 528 | 290 | 330 | 271 | 480 | 356 |
| Interest | 35 | 39 | 59 | 60 | 76 | 82 | 66 | 83 | 91 | 94 | 106 | 126 |
| Depreciation | 376 | 374 | 368 | 381 | 397 | 471 | 455 | 476 | 505 | 521 | 557 | 537 |
| Profit before tax | 1917 | 1829 | 1605 | 1883 | 1917 | 1874 | 2005 | 1905 | 1745 | 1543 | 200 | 553 |
| Tax % | 23 | 24 | 18 | 26 | 30 | 25 | 21 | 26 | 23 | 23 | -11 | 21 |
| Net Profit | 1482 | 1381 | 1310 | 1392 | 1342 | 1404 | 1587 | 1410 | 1337 | 1190 | 221 | 436 |
| EPS in Rs | 17.77 | 16.56 | 15.7 | 16.69 | 15.05 | 16.94 | 19.09 | 16.99 | 16.14 | 14.5 | 2.65 | 5.32 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 14281 | 15448 | 17517 | 19048 | 21545 | 24670 | 28011 | 32644 | 33700 | 33228 |
| Expenses | 11930 | 12270 | 15040 | 15173 | 17778 | 18200 | 20078 | 24097 | 27247 | 28088 |
| Operating Profit | 2351 | 3178 | 2477 | 3874 | 3768 | 6470 | 7933 | 8547 | 6454 | 5140 |
| OPM % | 16 | 21 | 14 | 20 | 17 | 26 | 28 | 26 | 19 | 15 |
| Other Income | 155 | 381 | 670 | 335 | 555 | 971 | 909 | 1119 | 1372 | 1437 |
| Interest | 79 | 89 | 98 | 97 | 96 | 143 | 171 | 283 | 374 | 416 |
| Depreciation | 1077 | 1135 | 1163 | 1229 | 1165 | 1250 | 1470 | 1704 | 2059 | 2119 |
| Profit before tax | 1350 | 2336 | 1886 | 2884 | 3061 | 6048 | 7201 | 7680 | 5393 | 4041 |
| Tax % | 32 | 17 | -7 | 32 | 29 | 25 | 23 | 25 | 23 | — |
| Net Profit | 947 | 1950 | 2026 | 1952 | 2182 | 4507 | 5578 | 5725 | 4158 | 3183 |
| EPS in Rs | 11.41 | 23.49 | 24.38 | 23.47 | 26.23 | 54.14 | 66.87 | 67.77 | 50.27 | 38.61 |
| Dividend Payout % | 35 | 17 | 21 | 21 | 23 | 15 | 12 | 12 | 16 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 84 |
| Reserves | 12179 | 12489 | 13941 | 15516 | 17558 | 19129 | 23203 | 28171 | 33466 | 37808 |
| Borrowings | 4918 | 5071 | 3838 | 2210 | 3031 | 3384 | 1347 | 2002 | 4677 | 7734 |
| Other Liabilities | 4474 | 4706 | 4557 | 5414 | 5915 | 7149 | 7576 | 8523 | 9797 | 10951 |
| Total Liabilities | 21654 | 22349 | 22418 | 23223 | 26588 | 29746 | 32209 | 38780 | 48023 | 56577 |
| Fixed Assets | 6931 | 6968 | 7191 | 6850 | 8206 | 8122 | 9219 | 10426 | 18226 | 22063 |
| CWIP | 3324 | 3470 | 2934 | 1535 | 1565 | 1293 | 1030 | 1419 | 2466 | 1460 |
| Investments | 2110 | 2298 | 2587 | 2678 | 2212 | 2616 | 4986 | 4930 | 4051 | 5285 |
| Other Assets | 9290 | 9612 | 9707 | 12160 | 14605 | 17715 | 16974 | 22004 | 23280 | 27768 |
| Total Assets | 21654 | 22349 | 22418 | 23223 | 26588 | 29746 | 32209 | 38780 | 48023 | 56577 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2144 | 1803 | 2870 | 2984 | 3570 | 2811 | 5888 | 4543 | 4643 | 5674 |
| Cash from Investing Activity | -1890 | -1483 | -769 | -495 | -2255 | -2565 | -4109 | -4034 | -5785 | -6425 |
| Cash from Financing Activity | -369 | -444 | -2133 | -2516 | -30 | -242 | -2686 | -376 | 1891 | 829 |
| Net Cash Flow | -114 | -124 | -31 | -27 | 1286 | 3 | -907 | 133 | 749 | 78 |
| Free Cash Flow | 926 | 713 | 2248 | 2412 | 2323 | 1238 | 4009 | 1908 | 1327 | 2004 |
| CFO/OP | 110 | 88 | 106 | 149 | 107 | 94 | 108 | 83 | 78 | 109 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 98 | 104 | 94 | 105 | 95 | 113 | 107 | 105 | 101 | 110 |
| Inventory Days | 282 | 263 | 273 | 230 | 273 | 250 | 232 | 283 | 260 | 228 |
| Days Payable | 104 | 121 | 111 | 100 | 109 | 111 | 108 | 116 | 97 | 91 |
| Cash Conversion Cycle | 275 | 246 | 256 | 235 | 259 | 252 | 231 | 271 | 264 | 247 |
| Working Capital Days | -14 | 39 | 65 | 59 | 57 | 61 | 84 | 118 | 69 | 68 |
| ROCE % | 9 | 8 | 13 | 11 | 16 | 14 | 27 | 27 | 23 | 13 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 26.66% | 26.65% | 26.65% | 26.65% | 26.64% | 26.64% | 26.64% | 26.64% | 26.64% | 26.64% | 26.63% | 26.64% |
| FIIs | 42.21% | 28.62% | 44.49% | 42.27% | 41.75% | 40.08% | 37.29% | 36.36% | 35.52% | 33.2% | 33.08% | 32.07% |
| DIIs | 21.04% | 16.21% | 18.31% | 20.73% | 21.48% | 22.9% | 25.62% | 26.74% | 27.98% | 30.44% | 30.72% | 31.74% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 7.91% | 8.44% | 8.25% | 8.07% | 8.07% | 8.07% | 8.2% | 8.04% | 7.56% | 7.65% | 7.57% | 7.42% |
| Others | 2.18% | 20.07% | 2.3% | 2.29% | 2.06% | 2.3% | 2.25% | 2.22% | 2.3% | 2.07% | 1.99% | 2.13% |
| No. of Shareholders | 243445 | 257794 | 255500 | 267694 | 310403 | 403669 | 459605 | 451929 | 449216 | 455243 | 449665 | 446086 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 5 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1153.66 | Buy |
| EMA (10) | 1156.64 | Buy |
| SMA (20) | 1167.63 | Sell |
| EMA (20) | 1165.06 | Buy |
| SMA (50) | 1191.53 | Sell |
| EMA (50) | 1192.73 | Sell |
| SMA (100) | 1247.75 | Sell |
| EMA (100) | 1220.83 | Sell |
| SMA (200) | 1250.98 | Sell |
| EMA (200) | 1236.8 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.72 | Neutral |
| MACD (12,26,9) | -12.19 | Buy |
| Stochastic (14,3,3) | 26.66 | Neutral |
| ADX (14) | 31.37 | Buy |
| Williams %R (14) | -47.17 | Neutral |
| ATR (14) | 21.31 | Neutral |
| ROC (12) | -1.4 | Sell |
| Stoch RSI (14) | 85.24 | Sell |
| UO (7,14,28) | 45.12 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 14 | 37.84% |
| Hold | 9 | 24.32% |
| Sell | 14 | 37.84% |

Based on 37 analyst ratings, observed at 2026-09-11T04:43:26.690728+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended March 31, 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29b55687-1cb9-45a0-96a9-900055e3b5f0.pdf) |
| 7h - Dr. Reddy’s approved ESOP grants: 8,16,119 Indian options and 3,76,115 ADR options on May 11, 2026. | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 7h - Dr. Reddy’s approved ESOP grants: 8,16,119 Indian options and 3,76,115 ADR options on May 11, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/357cb876-b6ef-4f24-a36c-15ab08d6a353.pdf) |
| 7 Apr - Dr Reddy’s sold Svaas Wellness on April 7, 2026 for INR 2.23 crore. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Sale Of Wholly Owned Subsidiary 7 Apr - Dr Reddy’s sold Svaas Wellness on April 7, 2026 for INR 2.23 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f988d58a-ecfb-46ef-abcb-b35a72f3ffec.pdf) |
| 6 Mar - DOJ closed FCPA inquiry on March 5, 2026; no enforcement recommended. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 6 Mar - DOJ closed FCPA inquiry on March 5, 2026; no enforcement recommended.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5ff7eba4-c667-4a72-ad92-cb91c9c4bd64.pdf) |
| 5 Mar - EIR received March 4, 2026: USFDA classified Srikakulam facility inspection as VAI; inspection closed. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 5 Mar - EIR received March 4, 2026: USFDA classified Srikakulam facility inspection as VAI; inspection closed.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a8596926-ca22-48c6-8ee7-756616f01944.pdf) |
| 29 Apr - Dr. Reddy’s received Health Canada NOC for generic semaglutide injection on April 29, 2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 29 Apr - Dr. Reddy’s received Health Canada NOC for generic semaglutide injection on April 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9fb0c46c-4f4c-4744-8a29-27bb0c4a33f8.pdf) |
| 29 Apr - Dr. Reddy’s received Health Canada NOC for generic semaglutide injection on April 29, 2026. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 29 Apr - Dr. Reddy’s received Health Canada NOC for generic semaglutide injection on April 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9fb0c46c-4f4c-4744-8a29-27bb0c4a33f8.pdf) |
| 27 Feb - Group meetings: 04.03.2026 Ambit Capital (Hyderabad, in-person); 05.03.2026 Goldman Sachs (virtual). | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Feb - Group meetings: 04.03.2026 Ambit Capital (Hyderabad, in-person); 05.03.2026 Goldman Sachs (virtual).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/faad9311-fe29-4d08-9da2-c9fe1c34d119.pdf) |
| 24 Mar - Board approved amended Code for Fair Disclosures on UPSI on March 24, 2026; uploaded to website. | [Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015 24 Mar - Board approved amended Code for Fair Disclosures on UPSI on March 24, 2026; uploaded to website.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2b56d7bc-d687-464a-8bd0-ff55b7391dde.pdf) |
| 24 Apr - Dr. Reddy's will announce Q4 and FY26 results on May 12, 2026, with earnings call at 19:30 IST. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 24 Apr - Dr. Reddy's will announce Q4 and FY26 results on May 12, 2026, with earnings call at 19:30 IST.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7dcf541f-f87f-4f2b-8dcc-00355d1bce00.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26921535-fcd1-4c7f-b3aa-3e48d21b16ff.pdf) |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=770d7a0d-ca7e-444c-ada4-0649eb6c7f97.pdf) |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=652ebfeb-4950-4291-83af-b74273d57ebd.pdf) |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e20d50b5-f3ea-49c6-9608-ad97db0958f6.pdf) |
| 2026-08-14 | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5C3DCE2D_4197_4511_AAAC_795D239DA321_121206.pdf) |
| 2026-08-14 | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46236493-6c1a-4382-a5ef-5d734b620629.pdf) |
| 2026-08-14 | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41c10d6f-1f55-4fd6-ad73-4d80be5125e7.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ba84592-5666-4053-ae62-82d09f257a80.pdf) |
| 2026-08-07 | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd8b05ff-1914-45fc-ba31-9278c00292bb.pdf) |
| 2026-08-07 | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42b06390-4ed1-4e79-81a3-8274d665c73f.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-22 | [Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7df38075-ad10-4e86-9fc3-b1768b2fed08.pdf) |
| 2026-05-12 | [Audited Financial Results For The Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e252c19f-df74-4a1a-b02f-475257f08d0f.pdf) |
| 2026-01-21 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6dbae8b-f9e1-430f-8f86-70258ef1e27d.pdf) |
| 2025-10-24 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5eb58ccd-f930-4ef7-838f-b3b129ccef23.pdf) |
| 2025-07-23 | [Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12e5364f-0652-4c3c-afc0-088141ba5f14.pdf) |
| 2025-05-09 | [Audited Financial Results For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2166525c-ff72-457d-94ae-60faea1824a9.pdf) |
| 2025-01-23 | [Outcome of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=AD7A94BF-9489-4AFA-9A20-DF74A4668F0D-172431.pdf) |
| 2024-11-05 | [Unaudited Financial Results For The Quarter And Half-Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ea4160e-a64c-4e23-bacf-a5ccee81ef2b.pdf) |
| 2024-07-27 | [Unaudited Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e30a5395-2c2f-4ebb-a28a-a512f01fbbef.pdf) |
| 2024-05-07 | [Outcome Of Board Meeting - Audited Financial Results For The Quarter And Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a88eec4-175f-400f-82ce-eecd5b7b3391.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d701ba41-32c6-4fe6-989d-94e734ec10a7.pdf) |
| 2026-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9156ec0d-1f58-4ef7-b858-4e7239bf1dfc.pdf) |
| 2026-05-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95588392-8071-413a-9d78-991bd1d87d4a.pdf) |
| 2026-01-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef2cbf94-0330-4ecd-a526-e5efc3b673b3.pdf) |
| 2025-10-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45e836ba-e747-490e-b57b-d4562e283952.pdf) |
| 2025-07-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6446fe27-f8da-4cd3-b147-d176e57c340f.pdf) |
| 2025-05-09 | [Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Incorporation Of Step Down Wholly-Owned Subsidiary](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1eec76c0-0b5e-4d02-81f9-00426300f249.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0953e6da-232b-4a0b-94ed-5348b8e2987d.pdf) |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0953e6da-232b-4a0b-94ed-5348b8e2987d.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2868c6b7-bf6b-43d2-befd-0a5bb4acd2ca.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2868c6b7-bf6b-43d2-befd-0a5bb4acd2ca.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29da498c-abc9-4d35-a023-4faa81a6a3ad.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29da498c-abc9-4d35-a023-4faa81a6a3ad.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9156ec0d-1f58-4ef7-b858-4e7239bf1dfc.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/95588392-8071-413a-9d78-991bd1d87d4a.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9156ec0d-1f58-4ef7-b858-4e7239bf1dfc.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/95588392-8071-413a-9d78-991bd1d87d4a.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b4d586a3-1dea-4aca-9bdc-143fa8564ad1.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/709c0d0e-a7a2-4c2a-a123-b09227a7f3f6.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cb3e5286-9df0-4e11-a250-fa17688f8266.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2025-07-23 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b38c391-0972-4cf3-9da1-e9fbb9eb3abd.pdf) |
| 2025-05-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3408ff2-52ad-4d42-983f-5bafd3d3d0c8.pdf) |
| 2024-11-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4525be9-9fc7-48f5-b128-ec7ea6e47b54.pdf) |
| 2024-07-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a958f9a-b6f5-4492-a6fd-8d0ceabd6c58.pdf) |
| 2024-06-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8432933-0f28-4951-b5de-c3ea172e492e.pdf) |
| 2024-05-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2b6ec3a-6cd7-4221-a636-f274b3cd54ed.pdf) |
| 2024-01-31 | [Audio Recordings Of The Earnings Call Conducted On January 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32ffe522-9b13-4717-8f5c-a35b8446fd8f.pdf) |
| 2023-10-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbc39f43-b4a7-49e0-84df-e3976b3db159.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:25:37.776Z.